Supplementary Table S3 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Supplementary Table S3 shows individual EC50 data for the inhibition of cell viability in a panel of KRAS-mutant cell lines treated with BBO-11818.